Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.
Daniel J LandsburgMitchell E HughesAlexa KoikeDavid BondKami J MaddocksLing GuoAllison M WinterBrian T HillSarah L OndrejkaEric D HsiSunita D NastaJakub SvobodaStephen J SchusterAgata M BoguszPublished in: Blood advances (2020)